ClinicalTrials.gg
RecruitingNCT07229365Updated Nov 3, 2026

Children's Viewing Behavior

An interventional study of Novel spectacle lens design and Spectacle lens designs in Myopia, Myopia Progression and Juvenile Myopia, sponsored by SightGlass Vision, Inc.. Recruiting at 1 site in United States. Open to participants aged 7 Years to 14 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by SightGlass Vision, Inc. · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started Dec 2025; still recruiting 10 months later.
Updated Nov 3, 2026Primary completion movedStudy completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
7 Years to 14 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 14 studies in Myopia by SightGlass Vision, Inc. — 3 open to participants now, 12 under way, none of them phase 3. Myopia · SightGlass Vision, Inc..

Planned enrollment
Largest of 14
300 · median 71
Started
2025
with 1 other
No phase
14 of 14
3 open now
Primary completion
2027-04
later than 10 of 11 live
Registered
13th of 14
by date

Among the 14 studies in Myopia by SightGlass Vision, Inc., this one has the largest planned enrollment, is one of 2 that started in 2025, is one of 14 with no phase, reaches primary completion later than 10 of the 11 other live ones, and was the 13th registered.

Myopia

1,166 studies on the registry are indexed under Myopia; 228 are open to participants now.

Browse Myopia studies →

Open to participants now

3 of the 14 studies in Myopia by SightGlass Vision, Inc. are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 3 open studies →

Where they have run

Who these studies take

Of the 124 Myopia studies recruiting now, 20 (16%) set no upper age limit and 103 (83%) stop at 75 or younger; 85 take children under 18; 53 take healthy volunteers.

This study: 7 Years to 14 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Myopia by SightGlass Vision, Inc., or all of them as a file.
02

Study summary

The aim of this study is to investigate the area of the spectacle lens in which a subject is viewing through regardless of task being performed.

03

Conditions studied

  • Myopia
  • Myopia Progression
  • Juvenile Myopia

Browse trials for

04

Who can participate

Ages eligible
7 Years to 14 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

A person is eligible for inclusion in the study if he/she:

  • Is 7-14 years of age, inclusive
  • Requires spherical spectacle lenses within the power range available for the study lenses
  • Parent/guardian has read and understood the form, and the child has provided age-appropriate assent
  • Is willing and able to follow instructions and maintain the appointment schedule
  • Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best corrected
  • Has had a self-reported oculo-visual examination in the last two years
  • Spectacle cylinder of ≤ -0.75DC in both eyes

Exclusion criteria

Exclusion Criteria:

A person will be excluded from the study if he/she:

  • Is unable to complete the necessary study activities
  • Has any systemic disease affecting ocular health
  • Is using any systemic or topical medications (including pharmaceutical myopia control therapy) that will affect ocular health
  • Is aphakic
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Participant)
Enrollment
300 participants (estimated)

Study arms

  • Experimental
    SightGlass Vision Test Arm 1

    Single vision, impact-resistant spectacle lenses

    Device: Novel spectacle lens design

  • Active comparator
    Control Arm

    Single vision, impact-resistant spectacle lenses

    Device: Spectacle lens designs

Interventions

  • DeviceNovel spectacle lens design

    Use of lenses to correct myopia and may reduce the rate of progression of juvenile myopia

  • DeviceSpectacle lens designs

    Use of lenses to correct myopia and may reduce the rate of progression of juvenile myopia

06

What researchers measure

Primary outcomes

  1. Activity dependent, gaze location in myopia control spectacles

    Time frame: 2 months

  2. Subjective/objective quantification of activity via survey or observation

    Time frame: 2 months

  3. Pupil size

    Time frame: 2 months

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Dec 2025 (actual). Primary completion is estimated for Apr 2027, 16 months after the start.

Of 236 industry-sponsored interventional studies with no phase under Myopia, half reached primary completion within 6 months of starting (the median), counting those still running; a quarter within 2 and three quarters within 24. This study's planned 16 months is above that.

Counting every sponsor, half of 438 studies reached it within 14 months; a quarter within 3 and three quarters within 34.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Dec 2026 → Apr 2027 and completion Jul 2027 → Dec 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Nov 12, 2025
First posted
Nov 17, 2025
StartActual
Dec 22, 2025
Primary completionEst.
Apr 30, 2027was Dec 2026
CompletionEst.
Dec 1, 2027was Jul 2027
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Dec 30, 2026→Apr 30, 2027
Nov 3, 2026
Study completion
Jul 1, 2027→Dec 1, 2027
Nov 3, 2026
Enrollment
20→300
Nov 3, 2026
Interventions
Added Device: Spectacle lens designs; removed Device: Spectacle lenses. Arm changed SightGlass Vision Test Arm 2→Control Arm
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Primary completion Dec 30, 2026→Apr 30, 2027
    Study completion Jul 1, 2027→Dec 1, 2027
    Enrollment 20→300
    Interventions Added Device: Spectacle lens designs; removed Device: Spectacle lenses. Arm changed SightGlass Vision Test Arm 2→Control Arm
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07229365
Lead sponsor
SightGlass Vision, Inc.
Responsible party
Sponsor
First posted
Nov 17, 2025
Start date
Dec 22, 2025
Primary completion
Apr 30, 2027 (estimated)
Completion
Dec 1, 2027 (estimated)
Last update
Nov 3, 2026

Study contacts

Jennifer Hill
Contact
jhill@sightglassvision.com
6783614877

Oversight

FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion